RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: vitiligo
Accession: DOID:12306
browse the term
Definition: An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes. (DO)
Synonyms: exact_synonym: SLEV1; VTLG; vitiligo-related systemic lupus erythematosus
related_synonym: AIS1; AIS2; AIS3; AIS4; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 4-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 7-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 8-RELATED; Autoimmune Disease, Susceptibility To, 1; Autoimmune Disease, Susceptibility To, 2; Autoimmune Disease, Susceptibility To, 3; Autoimmune Disease, Susceptibility To, 4; VAMAS1; VAMAS2; VAMAS3; VAMAS4; VAMAS5; VAMAS6; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 3; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 4; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 5; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6
primary_id: MESH:D014820
alt_id: OMIM:193200 ; OMIM:606579 ; OMIM:607836 ; OMIM:608391 ; OMIM:608392 ; OMIM:609400
xref: EFO:0004208 ; GARD:10751 ; ICD10CM:L80 ; ICD9CM:709.01 ; NCI:C26915
For additional species annotation, visit the
Alliance of Genome Resources .
G
BACH2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 6:87,806,188...88,175,840
Ensembl chr 6:91,083,533...91,160,552
G
C3
complement C3
ISO
RGD
PMID:12121667
RGD:7401277
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
C4A
complement C4A (Chido/Rodgers blood group)
ISO
associated with Graves Disease
RGD
PMID:21943165
RGD:5688264
NCBI chr 6:31,648,710...31,655,792
G
CASP7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr10:110,273,318...110,324,800
Ensembl chr10:113,707,780...113,758,626
G
CAT
catalase
susceptibility no_association
ISO
protein:decreased activity:skin: DNA:SNP,haplotype:promoter,cds:-89A>T,389C>T(human) DNA:SNPs:promoter,exon: -89A>T rs7943316), 389C>T (rs769217)(human)
RGD
PMID:19439879 PMID:20613769 PMID:23868633
RGD:9479149 RGD:9479150 RGD:9479169
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCR6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chr 6:165,094,563...165,109,774
Ensembl chr 6:170,069,689...170,084,779
G
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr11:35,110,732...35,258,238
Ensembl chr11:34,985,634...35,079,009
G
CD80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
G
CLNK
cytokine dependent hematopoietic cell linker
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 4:4,902,117...5,107,145
Ensembl chr 4:10,209,803...10,469,596
G
CLU
clusterin
ISO
RGD
PMID:7558712
RGD:8699503
NCBI chr 8:26,867,973...26,884,838
Ensembl chr 8:24,070,053...24,083,523
G
COMT
catechol-O-methyltransferase
no_association
ISO
DNA:polymorphism: :p.V158M (human)
RGD
PMID:19112571 PMID:24915010
RGD:8662333 RGD:8662336
NCBI chr22:2,704,015...2,731,326
Ensembl chr22:18,375,434...18,402,387
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association susceptibility
ISO
DNA:SNPs:multiple: DNA:SNP:exon:+49A>G rs231775)(human) DNA:SNP:3'UTR:rs3087243(human) associated with Autoimmune Diseases;DNA:polymorphisms: :
RGD
PMID:15649153 PMID:18200060 PMID:19129082 PMID:21794098
RGD:7411687 RGD:7411696 RGD:7411697 RGD:7411699
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
ESR1
estrogen receptor 1
no_association susceptibility
ISO
DNA:SNP:exon DNA:SNP:intron
RGD
PMID:15381239
RGD:8552976
NCBI chr 6:149,507,599...149,918,523
Ensembl chr 6:154,317,002...154,631,551
G
FOXD3
forkhead box D3
susceptibility
ISO
ClinVar Annotator: match by term: Autoimmune disease, susceptibility to, 1
OMIM ClinVar
PMID:16098053
NCBI chr 1:62,577,800...62,580,360
G
FOXP1
forkhead box P1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chr 3:70,893,933...71,523,892
Ensembl chr 3:72,258,456...72,498,173
G
HGF
hepatocyte growth factor
treatment
ISO
RGD
PMID:16117796
RGD:8548598
NCBI chr 7:73,667,618...73,738,960
Ensembl chr 7:87,327,798...87,397,811
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
treatment
ISO
RGD
PMID:23447019
RGD:8662840
NCBI chr 6:31,476,710...31,491,411
G
IFIH1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr2B:49,560,620...49,612,086
Ensembl chr2B:166,928,994...166,980,170
G
IFNG
interferon gamma
onset susceptibility
ISO
DNA:polymorphism:intron:rs2430561(human) DNA:repeats:intron:rs3138557(human)
RGD
PMID:23777204
RGD:8157616
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IKZF4
IKAROS family zinc finger 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr12:32,874,890...32,906,053
Ensembl chr12:33,124,994...33,155,269
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:23680073
RGD:8549591
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL17A
interleukin 17A
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:skin
CTD RGD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL2
interleukin 2
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL4
interleukin 4
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
ITK
IL2 inducible T cell kinase
ISO
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1
ClinVar
PMID:28492532 PMID:32628964 PMID:32888943
NCBI chr 5:152,582,125...152,656,211
Ensembl chr 5:159,204,016...159,277,689
G
KIF1B
kinesin family member 1B
ISO
ClinVar Annotator: match by term: Vitiligo
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:8,969,910...9,141,964
Ensembl chr 1:10,198,997...10,364,577 Ensembl chr 1:10,198,997...10,364,577
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphisms (human) DNA:polymorphism:HLA-DQB1*0201(human)
RGD
PMID:9653015 PMID:16420246
RGD:36174006 RGD:5147644
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
MBL2
mannose binding lectin 2
susceptibility no_association
ISO
DNA:polymorphism:exon: DNA:polymorphisms:promoter, exon:
RGD
PMID:17337399 PMID:19416237
RGD:8693723 RGD:8693724
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
MC1R
melanocortin 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr16:70,676,447...70,697,636
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NLRP1
NLR family pyrin domain containing 1
ISO
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1
ClinVar OMIM
PMID:17377159 PMID:25741868 PMID:27662089 PMID:28492532
NCBI chr17:5,562,129...5,667,765
Ensembl chr17:5,542,007...5,623,091
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chr 5:45,701,219...45,786,652
Ensembl chr 5:47,267,286...47,350,960
G
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:14551602
RGD:1578358
NCBI chr 6:32,423,614...32,429,062
Ensembl chr 6:33,539,060...33,564,402
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
ISO
DNA: snp : cds: rs2476601 DNA:polymorphism: :1858C>T (p.R620W) (human)
RGD
PMID:16015369 PMID:18426414
RGD:6484552 RGD:7829737
NCBI chr 1:88,685,736...88,743,164
Ensembl chr 1:123,734,511...123,790,830
G
SH2B3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr12:108,977,344...109,024,029
G
SLA
Src like adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr 8:129,690,546...129,757,660
Ensembl chr 8:132,666,411...132,732,669
G
SOD2
superoxide dismutase 2
disease_progression
ISO
DNA, mRNA, protein:SNPs, increased expression:cds:p.L84F (rs11575993), p.T58I (rs35289490), skin, leukocyte (human)
RGD
PMID:24036105
RGD:8547522
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
TGFB1
transforming growth factor beta 1
ISO
protein:decreased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
susceptibility
ISO
DNA:polymorphism:exon:p.R753Q(human)
RGD
PMID:22429552
RGD:7777152
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
susceptibility
ISO
DNA:polymorphism:exon:p.D299G(human)
RGD
PMID:22429552
RGD:7777152
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TOB2
transducer of ERBB2, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chr22:22,329,783...22,344,795
G
TYR
tyrosinase
severity
ISO
RGD
PMID:8697641 PMID:22834951
RGD:8694387 RGD:8694409
NCBI chr11:84,188,557...84,306,686
Ensembl chr11:87,769,606...87,888,138
G
VDR
vitamin D receptor
no_association
ISO
DNA:SNPs, haplotype: :multiple DNA:SNP:exon:rs2228570 (human) DNA:SNPs: :rs731236, rs1544410, rs7975232 (human)
RGD
PMID:22738935 PMID:22762534
RGD:8158061 RGD:8158066
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
G
DSTYK
dual serine/threonine and tyrosine protein kinase
ISO
ClinVar Annotator: match by term: DSTYK-related condition | ClinVar Annotator: match by term: Hereditary spastic paraplegia 23
OMIM ClinVar
PMID:17273976 PMID:23862974 PMID:25741868 PMID:27657687 PMID:28492532 PMID:28566479 PMID:33624863 More...
NCBI chr 1:180,750,987...180,820,096
Ensembl chr 1:185,041,994...185,107,041
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all